Seda’s mission is to maximise value through integrated Pharmaceutical Development and Clinical Pharmacology support. We enable rapid and efficient development of optimal medicinal products, from conventional to complex, through pragmatic and coherent scientific excellence. We provide clients with the experience and expertise found in the development functions of major pharmaceutical companies but with the speed and flexibility required by fast moving biotechs. We ensure that our systems, processes and project strategy have the agility to stay off the critical path. Enhancing the value proposition of our clients is our contribution to bringing new, innovative therapies to patients rapidly and successfully.
Our consultancy, laboratory and modelling services cover 4 important areas in the journey of a drug product from the latter stages of drug discovery through to approval and supply. These are Product Design, assessment of Product Performance, support to Product Authorisation and technical oversight of Product Supply.
We can support the development of a range of formulation types from conventional tablets and capsules to bioavailability enhancing formulations such as amorphous solid dispersions and semi-solid filled capsules, and have a processing suite for formulation of potent compounds. We also have capability in complex parenterals such as nucleic acid delivery systems, nanomedicines and long acting injectables. Our integrated clinical pharmacology support, underpinned by specialist in silico modelling enables a unique offering whereby products are designed for optimal biological performance alongside robust manufacturability.
Our consultancy, laboratory and modelling services cover 4 important areas in the journey of a drug product from the latter stages of drug discovery through to approval and supply. These are Product Design, assessment of Product Performance, support to Product Authorisation and technical oversight of Product Supply.
We can support the development of a range of formulation types from conventional tablets and capsules to bioavailability enhancing formulations such as amorphous solid dispersions and semi-solid filled capsules, and have a processing suite for formulation of potent compounds. We also have capability in complex parenterals such as nucleic acid delivery systems, nanomedicines and long acting injectables. Our integrated clinical pharmacology support, underpinned by specialist in silico modelling enables a unique offering whereby products are designed for optimal biological performance alongside robust manufacturability.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
